170 related articles for article (PubMed ID: 36969496)
1. Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-Transcriptome.
Wu G; Guo Y; Liu Y; Cai X; Deng T; Pei T; Huang L; Chen K; Pan X
J Immunol Res; 2023; 2023():5293677. PubMed ID: 36969496
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome Mapping of the Internal N7-Methylguanosine Methylome in Messenger RNAs in Human Oral Squamous Cell Carcinoma.
Li M; Song N; Sun D; Yu Y; Zheng W; Zhang X; Ying J; Sun R; Xu M; Guo T; Jiang Y
Front Biosci (Landmark Ed); 2023 Dec; 28(12):330. PubMed ID: 38179755
[TBL] [Abstract][Full Text] [Related]
3. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
4. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Xu Z; Jiang P; He S
Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Zhang YY; Mao MH; Han ZX
Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
[TBL] [Abstract][Full Text] [Related]
6. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma.
Tang B; Dong Y
J Gene Med; 2023 Jun; 25(6):e3490. PubMed ID: 36843559
[TBL] [Abstract][Full Text] [Related]
8. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
[TBL] [Abstract][Full Text] [Related]
9. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
Li CX; Su Y; Gong ZC; Liu H
Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
[TBL] [Abstract][Full Text] [Related]
11. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
[TBL] [Abstract][Full Text] [Related]
12. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
13. Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma.
Xu G; Wei J; Huangfu B; Gao J; Wang X; Xiao L; Xuan R; Chen Z; Song G
Mol Carcinog; 2020 Nov; 59(11):1302-1316. PubMed ID: 33006223
[TBL] [Abstract][Full Text] [Related]
14. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
Zhu R; Mao Y; Xu X; Li Y; Zheng J
Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
[TBL] [Abstract][Full Text] [Related]
15. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
16. PER2 binding to HSP90 enhances immune response against oral squamous cell carcinoma by inhibiting IKK/NF-κB pathway and PD-L1 expression.
Zhang Z; Sun D; Tang H; Ren J; Yin S; Yang K
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37914384
[TBL] [Abstract][Full Text] [Related]
17. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
[TBL] [Abstract][Full Text] [Related]
18. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
19. CircDOCK1 suppresses cell apoptosis via inhibition of miR‑196a‑5p by targeting BIRC3 in OSCC.
Wang L; Wei Y; Yan Y; Wang H; Yang J; Zheng Z; Zha J; Bo P; Tang Y; Guo X; Chen W; Zhu X; Ge L
Oncol Rep; 2018 Mar; 39(3):951-966. PubMed ID: 29286141
[TBL] [Abstract][Full Text] [Related]
20. Effect of benzo[a]pyrene on proliferation and metastasis of oral squamous cell carcinoma cells: A transcriptome analysis based on RNA-seq.
He H; Huang Y; Lu Y; Wang X; Ni H; Wu Y; Xia D; Ye D; Ding J; Mao Y; Teng Y
Environ Toxicol; 2022 Nov; 37(11):2589-2604. PubMed ID: 35870112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
